Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lapeyre

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2015
[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure]A Bellière-Calandry, C Benoît, S Dubois, et al.
European Journal of Clinical Pharmacology|January 30, 2004
Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria)E Sanz, M A Hernández, M Kumari, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
Annals of the Rheumatic Diseases|September 5, 2007
Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective studyL Sailler, C Pereira, A Bagheri, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2009
[Neck dissection following chemoradiation for node positive head and neck carcinomas]J Thariat, M Hamoir, F Janot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 6, 2021
[Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers]F Guillemin, J Miroir, L Piram, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
Clinical and Translational Radiation Oncology|August 28, 2024
Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factorsM Cuenin, A Levy, D Peiffert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2025
International guidelines for the delineation of the postoperative clinical target volumes (CTV) for parotid and submandibular gland cancersJ Biau, C Nutting, J A Langendijk, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2015
[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure]A Bellière-Calandry, C Benoît, S Dubois, et al.
European Journal of Clinical Pharmacology|January 30, 2004
Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria)E Sanz, M A Hernández, M Kumari, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
Annals of the Rheumatic Diseases|September 5, 2007
Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective studyL Sailler, C Pereira, A Bagheri, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2009
[Neck dissection following chemoradiation for node positive head and neck carcinomas]J Thariat, M Hamoir, F Janot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 6, 2021
[Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers]F Guillemin, J Miroir, L Piram, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
Clinical and Translational Radiation Oncology|August 28, 2024
Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factorsM Cuenin, A Levy, D Peiffert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2025
International guidelines for the delineation of the postoperative clinical target volumes (CTV) for parotid and submandibular gland cancersJ Biau, C Nutting, J A Langendijk, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Pageof 19